The next oral peptide story is an immune drug
Icotrokinra, the FDA-approved oral peptide IL-23 receptor antagonist for plaque psoriasis, shows how peptide pills are moving from metabolic medicine into immunology.
Tag
Macrocyclic peptides
Pages related to Macrocyclic peptides.
The oral peptide story is moving beyond weight loss
Enlicitide, an oral macrocyclic peptide PCSK9 inhibitor, is turning cholesterol treatment into a test case for whether complex peptides can become everyday pills.
Cyclic peptides are moving into the mitochondria story
A new macrocyclic peptide inhibitor aimed at pathological mitochondrial fission shows why cyclic peptides are becoming serious tools for protein-protein interaction drug design, not just niche chemistry.